Surgical treatment of type IV choledochal cysts

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• The optimal surgical management for type IV choledochal cysts remains debated.
• Choledochal cysts are congenital dilations of the bile ducts, with type IV involving multiple dilations within and outside the liver.
• Pancreatobiliary maljunction (PBMJ) is often associated with choledochal cysts and carries an increased risk of malignancy.

Purpose of the Study:

• To evaluate the surgical outcomes and long-term results of managing type IV choledochal cysts.
• To compare the efficacy of different surgical approaches regarding malignancy development and patient survival.
• To determine the benefit of total bile duct resection in preventing cancer in patients with type IV choledochal cysts.

Main Methods:

• Retrospective analysis of 13 patients with type IV choledochal cysts who underwent surgical management.
• Surgical approaches included resection of the extrahepatic bile duct (EHBD) with hepaticojejunostomy (HJ), and total bile duct excision with PBMJ removal (hepatectomy and/or pancreaticoduodenectomy).
• Long-term follow-up was conducted to monitor for malignancy development and patient survival.

Main Results:

• Younger patients (25-35 years) treated with EHBD resection and HJ showed no malignancies.
• Older patients (50-68 years) had a 27.5% incidence of gallbladder or bile duct cancer.
• Cancer developed in the remnant bile duct in one patient who underwent EHBD resection alone, while no cancers were detected in patients with total excision and partial hepatectomy.

Conclusions:

• Total excision of the dilated bile duct, including associated PBMJ, is recommended for type IV choledochal cysts.
• This radical surgical approach is crucial for preventing cancer in the remnant bile duct and improving long-term survival rates.
• The frequent association of PBMJ with malignancy underscores the need for comprehensive surgical resection.